ECO Animal Health Group plc (AIM:EAH)

Market Cap	62.68M
Revenue (ttm)	79.60M
Net Income (ttm)	1.69M
Shares Out	67.76M
EPS (ttm)	0.02
PE Ratio	38.07
Forward PE	30.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,008
Average Volume	82,610
Open	93.89
Previous Close	92.50
Day's Range	91.88 - 93.89
52-Week Range	50.00 - 100.00
Beta	-0.02
RSI	59.41
Earnings Date	Nov 25, 2025

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infectio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 224
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EAH

Financial Performance

In 2024, ECO Animal Health Group's revenue was 79.60 million, a decrease of -10.99% compared to the previous year's 89.42 million. Earnings were 1.69 million, an increase of 60.88%.